Literature DB >> 33515430

A Dominant C150Y Mutation in FHL1 Induces Structural Alterations in LIM2 Domain Causing Protein Aggregation In Human and Drosophila Indirect Flight Muscles.

Rashmi Santhoshkumar1, Veeramani Preethish-Kumar2, Kiran K Mangalaparthi3, Sruthi Unni4, Balasundaram Padmanabhan4, Keshava Prasad T S5, Upendra Nongthomba6, Nalini Atchayaram2, Gayathri Narayanappa7.   

Abstract

FHL1-related myopathies are rare X-linked dominant myopathies. Though clinically classified into several subgroups, spinal and scapuloperoneal muscle involvement are common to all. In this study, we identified c.449G > A, p.C150Y mutation by clinical exome sequencing in two patients from same family (son and mother) of Indian origin who presented with multiple contractures. Muscle biopsy showed numerous intracytoplasmic aggregates intensely stained on HE and MGT. The strong reactions to M-NBT revealed aggregates to be reducing bodies and positively labeled to anti-FHL1 antibody. Ultrastructurally, Z-band streaming and granular and granulofilamentous material were seen. Further, the translational evidence of mutant peptide was confirmed using mass spectrometric analysis. To establish p.C150Y as the cause for protein aggregation, in vivo studies were carried out using transgenic Drosophila model which highlighted Z-band abnormalities and protein aggregates in indirect flight muscles with compromised physiological function. Thus, recapitulating the X-linked human disease phenotype. Additionally, the molecular dynamics simulation analysis unraveled the drastic change in α-helix of LIM2, the region immediately next to site of C150Y mutation that could be the plausible cause for protein aggregation. To the best of our knowledge, this is the first study of p.C150Y mutation in FHL1 identified in Indian patients with in vivo and in silico analysis to establish the cause for protein aggregation in muscle.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Drosophila melanogaster; FHL1; Mass spectrometry; Molecular dynamics simulation; Mutation; Reducing body

Mesh:

Substances:

Year:  2021        PMID: 33515430     DOI: 10.1007/s12031-020-01777-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  23 in total

1.  A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations.

Authors:  M Keßler; A Kieltsch; E Kayvanpour; H A Katus; B Schoser; J Schessl; S Just; W Rottbauer
Journal:  Neuromuscul Disord       Date:  2018-03-15       Impact factor: 4.296

Review 2.  The LIM domain: from the cytoskeleton to the nucleus.

Authors:  Julie L Kadrmas; Mary C Beckerle
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

Review 3.  Protein misfolding disorders: pathogenesis and intervention.

Authors:  N Gregersen
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

4.  Characterisation of missense mutations in the Act88F gene of Drosophila melanogaster.

Authors:  D R Drummond; E S Hennessey; J C Sparrow
Journal:  Mol Gen Genet       Date:  1991-04

5.  Adult onset reducing body myopathy.

Authors:  D Figarella-Branger; G A Putzu; C Bouvier-Labit; J Pouget; D Chateau; M Fardeau; J F Pellissier
Journal:  Neuromuscul Disord       Date:  1999-12       Impact factor: 4.296

Review 6.  Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features.

Authors:  Belinda S Cowling; Denny L Cottle; Brendan R Wilding; Colleen E D'Arcy; Christina A Mitchell; Meagan J McGrath
Journal:  Neuromuscul Disord       Date:  2011-04       Impact factor: 4.296

7.  FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy.

Authors:  ZhenXian Hu; Ying Zhu; Xiao Liu; Wei Zhang; Jing Liu; Shiwen Wu; Jiangxi Xiao; Yun Yuan; Zhaoxia Wang
Journal:  J Hum Genet       Date:  2019-07-04       Impact factor: 3.172

8.  A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations.

Authors:  Dong-Hui Chen; Wendy H Raskind; William W Parson; Joshua A Sonnen; Tiffany Vu; Yunlin Zheng; Mark Matsushita; John Wolff; Hillary Lipe; Thomas D Bird
Journal:  J Neurol Sci       Date:  2010-07-14       Impact factor: 3.181

9.  Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy.

Authors:  Lucie Gueneau; Anne T Bertrand; Jean-Philippe Jais; Mustafa A Salih; Tanya Stojkovic; Manfred Wehnert; Maria Hoeltzenbein; Simone Spuler; Shinji Saitoh; Annie Verschueren; Christine Tranchant; Maud Beuvin; Emmanuelle Lacene; Norma B Romero; Simon Heath; Diana Zelenika; Thomas Voit; Bruno Eymard; Rabah Ben Yaou; Gisèle Bonne
Journal:  Am J Hum Genet       Date:  2009-08-27       Impact factor: 11.025

10.  Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice.

Authors:  Andrea A Domenighetti; Pao-Hsien Chu; Tongbin Wu; Farah Sheikh; David S Gokhin; Ling T Guo; Ziyou Cui; Angela K Peter; Danos C Christodoulou; Michael G Parfenov; Joshua M Gorham; Daniel Y Li; Indroneal Banerjee; Xianyin Lai; Frank A Witzmann; Christine E Seidman; Jonathan G Seidman; Aldrin V Gomes; G Diane Shelton; Richard L Lieber; Ju Chen
Journal:  Hum Mol Genet       Date:  2013-08-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.